Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
TRUALT

TruAlt Bioenergy Share Price

 

 

TruAlt Bioenergy live price: ₹492.45. It opened at ₹488 vs previous close ₹486; intraday high/low: ₹499/₹487. The 50 DMA stands at ₹426.79.

TruAlt Bioenergy Performance

  • Today's Low
  • ₹487
  • Today's High
  • ₹499
  • 52 Week Low
  • ₹310
  • 52 Week High
  • ₹549
  • Open Price₹488
  • Previous Close₹486
  • Volume365,632
  • 50 DMA₹426.79
  • 100 DMA₹424.06
  • 200 DMA-

TruAlt Bioenergy Chart

Investment Returns

  • Over 1 Month + 19.89%
  • Over 3 Month + 30.23%
  • Over 6 Month + 10.39%
  • Over 1 Year -0.72%

Smart Investing Starts Here Start SIP with TruAlt Bioenergy for Steady Growth!

Invest Now

TruAlt Bioenergy Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 28.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 4,223
  • P/B Ratio
  • 2.9
  • Average True Range
  • 21.17
  • EPS
  • 17.24
  • Dividend Yield
  • 0
  • MACD Signal
  • 18.06
  • RSI
  • 72.55
  • MFI
  • 87.33

TruAlt Bioenergy Financials

TruAlt Bioenergy Technicals

EMA & SMA

Current Price
₹492.45
+ 6.4 (1.32%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 13
  • 20 Day
  • ₹451.21
  • 50 Day
  • ₹426.79
  • 100 Day
  • ₹424.06
  • 200 Day
  • -

Resistance and Support

492.85 Pivot Speed
  • R3 510.50
  • R2 504.75
  • R1 498.60
  • S1 486.70
  • S2 480.95
  • S3 474.80

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

TruAlt Bioenergy is India’s largest ethanol producer by installed capacity and a diversified biofuels leader. Its portfolio spans ethanol, CBG, ENA, and organic manure, with upcoming ventures in 2G ethanol, sustainable aviation fuel, and green hydrogen for clean energy transition.

Trualt Bioenergy Ltd has an operating revenue of Rs. 2,038.98 Cr. on a trailing 12-month basis. An annual revenue growth of 54% is outstanding, Pre-tax margin of 8% is okay, ROE of 19% is exceptional. The company has a high debt to equity of 145%, which can be a reason to worry. The stock from a technical standpoint is comfortably placed above its key moving averages, around 18% and 17% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 48 which is a POOR score indicating inconsistency in earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 48 indicates it belongs to a fair industry group of Energy-Alternative/Other and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

TruAlt Bioenergy Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-03 Quarterly Results
2025-11-11 Quarterly Results
2025-10-19 Quarterly Results

TruAlt Bioenergy Shareholding Pattern

70.55%
6.7%
0.38%
0.66%
0%
13.5%
8.21%

TruAlt Bioenergy FAQs

TruAlt Bioenergy share price is ₹492 As on 02 May, 2026 | 22:51

The Market Cap of TruAlt Bioenergy is ₹4222.9 Cr As on 02 May, 2026 | 22:51

The P/E ratio of TruAlt Bioenergy is 28.6 As on 02 May, 2026 | 22:51

The PB ratio of TruAlt Bioenergy is 2.9 As on 02 May, 2026 | 22:51

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23